Aging of the upper face commonly leads to a sensation of eyelid heaviness, resulting from brow descent, redundant upper eyelid skin, or both. ¹ Upper eyelid blepharoplasty, or eyelid lift, corrects redundant skin and differs from brow lift surgery, which elevates the eyebrow; in selected cases, both procedures may be combined to optimize functional and aesthetic outcomes. ^{2, 3} Age-related morphological changes, including elastolysis, collagen remodeling, and fat redistribution, contribute to dermatochalasis, which can cause aesthetic concerns, visual field obstruction, and psychological distress. ^{4, 5} Management requires careful evaluation and individualized treatment planning by surgeons experienced in periocular surgery. Available treatments range from nonsurgical approaches, such as botulinum toxin (BT) injections and energy-based devices, to definitive surgical correction via blepharoplasty. ^{6, 7} Although nonsurgical interventions are minimally invasive, repeated or improperly administered periocular BT injections can lead to functional disturbances such as eyelid heaviness, ptosis, ocular fatigue, and aesthetic dissatisfaction, ultimately necessitating surgical intervention. ^{8– 11}

A 45-year-old Syrian man presented to the Department of Oral and Maxillofacial Surgery, Damascus University, in 2024 with complaints of bilateral upper eyelid dermatochalasis and a two-year history of repeated periocular botulinum toxin (BT) injections (two sessions every three months). While initial improvement was noted, he experienced recurrence of eyelid skin redundancy accompanied by headaches, ocular heaviness, and functional discomfort. Clinical examination revealed bilateral upper eyelid skin redundancy with mild lateral hooding and intact levator function. Superior visual field restriction was documented. Given the persistence of functional impairment and aesthetic dissatisfaction, bilateral upper eyelid blepharoplasty was planned. Intraoperatively, excessive preaponeurotic fat was identified and carefully excised along with redundant skin, while preserving the levator apparatus and orbital septum. A small segment of the orbicularis oculi muscle was also removed to enhance eyelid contour. The procedure was completed without intraoperative complications. Postoperatively, the patient reported complete resolution of eyelid heaviness and subjective improvement in the visual field ( Figure 1). Aesthetic results were favorable, demonstrating improved eyelid contour and symmetry. Patient-reported satisfaction, measured using the Blepharoplasty Outcomes Evaluation (BOE) questionnaire, increased from 25% preoperatively to 96.8% at both three and six months follow-up.

The upper eyelid is composed of skin, subcutaneous areolar tissue, striated muscle, submuscular areolar tissue, tarsi, and the orbital septum. With aging, these structures undergo progressive morphological changes, which may be further accentuated in patients receiving repeated botulinum toxin (BT) injections for periorbital rejuvenation. ¹⁴ Dermatochalasis, characterized by redundant upper eyelid skin, is a hallmark of periorbital aging and may impair ocular function through lateral hooding and superolateral visual field obstruction. ¹⁵ Age-related elastolysis, collagen remodeling, loss of ground substance, and dermal thinning contribute to decreased skin elasticity, while gravitational forces and diminished subcutaneous support exacerbate tissue redundancy. ^{16, 17} Fat redistribution and weakening of connective tissue further influence the periorbital–cheek transition, intensifying the clinical presentation. ^{14, 18}

BT injections have gained popularity for upper-face rejuvenation because of their rapid and reproducible effects in reducing dynamic wrinkles, particularly in the glabella, forehead, and crow’s feet regions. ^{19, 20} Although generally safe, BT administration can cause complications, including blepharoptosis, eyebrow asymmetry, headache, diplopia, lagophthalmos, ectropion, and xerophthalmia. Improper technique or excessive dosing can exacerbate eyelid heaviness, lateral hooding, and visual field obstruction. ^{21– 23}

In this case, despite multiple BT treatments, the patient developed persistent dermatochalasis and functional symptoms that required surgical correction. Upper eyelid blepharoplasty successfully addressed both functional and aesthetic concerns, with intraoperative excision of redundant skin, removal of preaponeurotic fat, and partial excision of the orbicularis oculi muscle performed while preserving the levator apparatus and orbital septum. Careful hemostasis minimized postoperative edema and ecchymosis. Postoperatively, the patient reported resolution of heaviness, improvement in visual field, and high satisfaction, with BOE scores increasing from 25% preoperatively to 96.8% at six months.

This case underscores that while BT is a valuable nonsurgical tool, it does not substitute for surgery in patients with significant dermatochalasis or fat herniation. Blepharoplasty remains the gold standard for restoring eyelid function and contour. Optimal results require precise intraoperative assessment, preservation of critical anatomical structures, and meticulous surgical technique, as demonstrated in this case and supported by previous studies.

Repeated botulinum toxin injections may provide temporary periorbital rejuvenation but can lead to functional complications, particularly in patients with underlying dermatochalasis. Upper eyelid blepharoplasty offers a definitive solution, effectively restoring eyelid function, contour, and symmetry. In this case, meticulous excision of redundant skin, careful fat management, and preservation of key anatomical structures resulted in complete symptom resolution and high patient satisfaction. This report underscores the limitations of nonsurgical interventions and reinforces blepharoplasty as the gold standard for comprehensive management of upper eyelid aging, even in patients with a history of prior botulinum toxin treatment.

Written informed consent was obtained from the patient for the publication of their clinical details and images. The patient has seen the manuscript and agreed to its publication.

Ethical approval was provided by the Biomedical Research Ethics Committee (DN-020624-234) on 2 June 2024.

Clinical and intraoperative photographs were captured using a high-resolution mobile phone camera under standardized lighting conditions.

No supplementary material is associated with this article.